nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfanilamide—CYP3A4—bone cancer	0.965	1	CbGaD
Sulfanilamide—CYP2E1—Felbamate Metabolism—CYP3A4—bone cancer	0.0036	0.109	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—CITED2—bone cancer	0.00306	0.0928	CbGpPWpGaD
Sulfanilamide—CYP2E1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00118	0.0359	CbGpPWpGaD
Sulfanilamide—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000912	0.0277	CbGpPWpGaD
Sulfanilamide—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000842	0.0256	CbGpPWpGaD
Sulfanilamide—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000839	0.0255	CbGpPWpGaD
Sulfanilamide—CYP2C9—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000832	0.0252	CbGpPWpGaD
Sulfanilamide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—bone cancer	0.000795	0.0241	CbGpPWpGaD
Sulfanilamide—CYP2E1—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000682	0.0207	CbGpPWpGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000639	0.0194	CbGpPWpGaD
Sulfanilamide—Sulfadiazine—CYP3A4—bone cancer	0.00062	0.336	CrCbGaD
Sulfanilamide—CYP2E1—Xenobiotics—CYP3A4—bone cancer	0.00057	0.0173	CbGpPWpGaD
Sulfanilamide—CYP2E1—Tamoxifen metabolism—CYP3A4—bone cancer	0.000549	0.0167	CbGpPWpGaD
Sulfanilamide—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000548	0.0166	CbGpPWpGaD
Sulfanilamide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000516	0.0157	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metapathway biotransformation—CYP4V2—bone cancer	0.000509	0.0154	CbGpPWpGaD
Sulfanilamide—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000484	0.0147	CbGpPWpGaD
Sulfanilamide—Sulfamethoxazole—CYP3A4—bone cancer	0.00048	0.26	CrCbGaD
Sulfanilamide—CA9—Cellular responses to stress—BMI1—bone cancer	0.000451	0.0137	CbGpPWpGaD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000449	0.0136	CbGpPWpGaD
Sulfanilamide—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.00044	0.0134	CbGpPWpGaD
Sulfanilamide—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000423	0.0128	CbGpPWpGaD
Sulfanilamide—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000405	0.0123	CbGpPWpGaD
Sulfanilamide—CYP2C9—Xenobiotics—CYP3A4—bone cancer	0.000401	0.0122	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000392	0.0119	CbGpPWpGaD
Sulfanilamide—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000389	0.0118	CbGpPWpGaD
Sulfanilamide—CYP2C9—Tamoxifen metabolism—CYP3A4—bone cancer	0.000386	0.0117	CbGpPWpGaD
Sulfanilamide—Dapsone—CYP3A4—bone cancer	0.000376	0.204	CrCbGaD
Sulfanilamide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000373	0.0113	CbGpPWpGaD
Sulfanilamide—Dapsone—PTGS2—bone cancer	0.000368	0.2	CrCbGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000361	0.011	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CYP4V2—bone cancer	0.000358	0.0109	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—NDUFA12—bone cancer	0.000302	0.00918	CbGpPWpGaD
Sulfanilamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000302	0.00917	CbGpPWpGaD
Sulfanilamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000296	0.00899	CbGpPWpGaD
Sulfanilamide—CYP2E1—Tryptophan metabolism—CYP3A4—bone cancer	0.000293	0.00889	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—NDUFA12—bone cancer	0.000282	0.00857	CbGpPWpGaD
Sulfanilamide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000276	0.00836	CbGpPWpGaD
Sulfanilamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000262	0.00797	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—NDUFA12—bone cancer	0.000261	0.00794	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—NT5C3A—bone cancer	0.000251	0.0076	CbGpPWpGaD
Sulfanilamide—CA9—HIF-1-alpha transcription factor network—JUN—bone cancer	0.000242	0.00734	CbGpPWpGaD
Sulfanilamide—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000237	0.00719	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000236	0.00716	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—NT5C3A—bone cancer	0.000234	0.0071	CbGpPWpGaD
Sulfanilamide—CYP2E1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000234	0.0071	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—EZH2—bone cancer	0.000219	0.00665	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—NT5C3A—bone cancer	0.000217	0.00658	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—NDUFA12—bone cancer	0.0002	0.00607	CbGpPWpGaD
Sulfanilamide—CYP2E1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000192	0.00583	CbGpPWpGaD
Sulfanilamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000183	0.00555	CbGpPWpGaD
Sulfanilamide—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00018	0.00547	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—GSTP1—bone cancer	0.000171	0.00518	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—NDUFA12—bone cancer	0.000168	0.00511	CbGpPWpGaD
Sulfanilamide—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000168	0.0051	CbGpPWpGaD
Sulfanilamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000167	0.00506	CbGpPWpGaD
Sulfanilamide—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000166	0.00504	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—NT5C3A—bone cancer	0.000166	0.00503	CbGpPWpGaD
Sulfanilamide—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000164	0.00499	CbGpPWpGaD
Sulfanilamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000148	0.0045	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—NT5C3A—bone cancer	0.00014	0.00424	CbGpPWpGaD
Sulfanilamide—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000136	0.00414	CbGpPWpGaD
Sulfanilamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000135	0.0041	CbGpPWpGaD
Sulfanilamide—CYP2E1—Tryptophan metabolism—MDM2—bone cancer	0.000135	0.00409	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—CDK4—bone cancer	0.000124	0.00375	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—ENO2—bone cancer	0.00011	0.00333	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—RB1—bone cancer	0.000108	0.00327	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—ENO2—bone cancer	0.000102	0.00311	CbGpPWpGaD
Sulfanilamide—CYP2E1—Biological oxidations—CYP3A4—bone cancer	0.000102	0.0031	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—DHFR—bone cancer	0.000102	0.00309	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metapathway biotransformation—CYP3A4—bone cancer	0.000101	0.00305	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—GNA11—bone cancer	9.51e-05	0.00289	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—DHFR—bone cancer	9.5e-05	0.00288	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—ENO2—bone cancer	9.49e-05	0.00288	CbGpPWpGaD
Sulfanilamide—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	9.37e-05	0.00284	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—MDM2—bone cancer	9.17e-05	0.00278	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—GNA11—bone cancer	8.88e-05	0.0027	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—DHFR—bone cancer	8.8e-05	0.00267	CbGpPWpGaD
Sulfanilamide—CYP2E1—Biological oxidations—GSTP1—bone cancer	8.72e-05	0.00265	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—CYP3A4—bone cancer	8.63e-05	0.00262	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metapathway biotransformation—GSTP1—bone cancer	8.6e-05	0.00261	CbGpPWpGaD
Sulfanilamide—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	8.54e-05	0.00259	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—GNA11—bone cancer	8.23e-05	0.0025	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—CYP3A4—bone cancer	8.05e-05	0.00244	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—JUN—bone cancer	7.97e-05	0.00242	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—CYP3A4—bone cancer	7.87e-05	0.00239	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	7.76e-05	0.00236	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—CYP3A4—bone cancer	7.46e-05	0.00226	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—GSTP1—bone cancer	7.38e-05	0.00224	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—ENO2—bone cancer	7.26e-05	0.0022	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—CYP3A4—bone cancer	7.24e-05	0.0022	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—CYP3A4—bone cancer	7.18e-05	0.00218	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	7.14e-05	0.00217	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	7.08e-05	0.00215	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—GSTP1—bone cancer	6.89e-05	0.00209	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—DHFR—bone cancer	6.73e-05	0.00204	CbGpPWpGaD
Sulfanilamide—CYP2C19—Biological oxidations—GSTP1—bone cancer	6.73e-05	0.00204	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	6.64e-05	0.00201	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—GSTP1—bone cancer	6.38e-05	0.00194	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—GNA11—bone cancer	6.29e-05	0.00191	CbGpPWpGaD
Sulfanilamide—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	6.25e-05	0.0019	CbGpPWpGaD
Sulfanilamide—CYP2D6—Biological oxidations—GSTP1—bone cancer	6.19e-05	0.00188	CbGpPWpGaD
Sulfanilamide—CYP2C9—Biological oxidations—GSTP1—bone cancer	6.14e-05	0.00186	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—ENO2—bone cancer	6.12e-05	0.00186	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NDUFA12—bone cancer	6.11e-05	0.00186	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	6.11e-05	0.00185	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.05e-05	0.00184	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—CYP3A4—bone cancer	5.7e-05	0.00173	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—DHFR—bone cancer	5.67e-05	0.00172	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GNA11—bone cancer	5.3e-05	0.00161	CbGpPWpGaD
Sulfanilamide—CA9—Cellular responses to stress—TP53—bone cancer	5.26e-05	0.0016	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—NT5C3A—bone cancer	5.07e-05	0.00154	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—GSTP1—bone cancer	4.88e-05	0.00148	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—CYP3A4—bone cancer	4.81e-05	0.00146	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NDUFA12—bone cancer	4.72e-05	0.00143	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NDUFA12—bone cancer	4.34e-05	0.00132	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NDUFA12—bone cancer	4.3e-05	0.00131	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—GSTP1—bone cancer	4.11e-05	0.00125	CbGpPWpGaD
Sulfanilamide—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.05e-05	0.00123	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.99e-05	0.00121	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—NT5C3A—bone cancer	3.91e-05	0.00119	CbGpPWpGaD
Sulfanilamide—CA6—Metabolism—PTGS2—bone cancer	3.82e-05	0.00116	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—NT5C3A—bone cancer	3.59e-05	0.00109	CbGpPWpGaD
Sulfanilamide—CA7—Metabolism—PTGS2—bone cancer	3.57e-05	0.00108	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—NT5C3A—bone cancer	3.56e-05	0.00108	CbGpPWpGaD
Sulfanilamide—CA12—Metabolism—PTGS2—bone cancer	3.31e-05	0.001	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NDUFA12—bone cancer	2.84e-05	0.000861	CbGpPWpGaD
Sulfanilamide—CA2—Metabolism—PTGS2—bone cancer	2.53e-05	0.000767	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—NT5C3A—bone cancer	2.35e-05	0.000713	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—ENO2—bone cancer	2.22e-05	0.000674	CbGpPWpGaD
Sulfanilamide—CA9—Metabolism—PTGS2—bone cancer	2.13e-05	0.000647	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—DHFR—bone cancer	2.06e-05	0.000625	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GNA11—bone cancer	1.92e-05	0.000584	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—CYP3A4—bone cancer	1.74e-05	0.00053	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—ENO2—bone cancer	1.71e-05	0.00052	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—DHFR—bone cancer	1.59e-05	0.000482	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—ENO2—bone cancer	1.57e-05	0.000478	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—ENO2—bone cancer	1.56e-05	0.000474	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—GSTP1—bone cancer	1.49e-05	0.000453	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GNA11—bone cancer	1.48e-05	0.000451	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—DHFR—bone cancer	1.46e-05	0.000443	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—DHFR—bone cancer	1.45e-05	0.00044	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GNA11—bone cancer	1.37e-05	0.000414	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GNA11—bone cancer	1.35e-05	0.000411	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—CYP3A4—bone cancer	1.35e-05	0.000409	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.34e-05	0.000406	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—CYP3A4—bone cancer	1.24e-05	0.000376	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—CYP3A4—bone cancer	1.23e-05	0.000372	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.22e-05	0.000371	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—GSTP1—bone cancer	1.15e-05	0.000349	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—GSTP1—bone cancer	1.06e-05	0.000321	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—GSTP1—bone cancer	1.05e-05	0.000319	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—ENO2—bone cancer	1.03e-05	0.000313	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—DHFR—bone cancer	9.55e-06	0.00029	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GNA11—bone cancer	8.93e-06	0.000271	CbGpPWpGaD
Sulfanilamide—CYP2E1—Metabolism—PTGS2—bone cancer	7.73e-06	0.000235	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—GSTP1—bone cancer	6.92e-06	0.00021	CbGpPWpGaD
Sulfanilamide—CYP2C19—Metabolism—PTGS2—bone cancer	5.96e-06	0.000181	CbGpPWpGaD
Sulfanilamide—CYP2D6—Metabolism—PTGS2—bone cancer	5.48e-06	0.000166	CbGpPWpGaD
Sulfanilamide—CYP2C9—Metabolism—PTGS2—bone cancer	5.44e-06	0.000165	CbGpPWpGaD
Sulfanilamide—CYP3A4—Metabolism—PTGS2—bone cancer	3.59e-06	0.000109	CbGpPWpGaD
